Evidence map›Paper›PMID 32691177›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Evaluation of serum uric levels in migraine.

Tamer Yazar, Hülya Olgun Yazar, Ali Aygün, Volkan Karabacak, Yavuz Altunkaynak, Dursun Kirbaş

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Oxidative Stress and Migraine.Molecular neurobiology · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Tamer YazarNeurology, Zeytinburnu Surp Pirgıç Armenian Hospital, Zakirbaşı Sokak No:32, 34020, Kazlıçeşme, İstanbul, Turkey. tamer.yazar@yahoo.com.tr.ORCID https://orcid.org/0000-0003-3054-6613
Hülya Olgun YazarOrdu University Education and Research Hospital, Ordu, Turkey.ORCID https://orcid.org/0000-0003-2768-6092
Ali AygünFaculty of Medicine, Department of Emergency Medicine, Ordu University, Ordu, Turkey.ORCID https://orcid.org/0000-0002-5190-1445
Volkan KarabacakHealth Department of Public Health, Ordu, Turkey.ORCID https://orcid.org/0000-0002-8575-990X
Yavuz AltunkaynakDr. Mazhar Osman Psychiatric and Neurological Diseases Education and Research Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-4921-1592
Dursun KirbaşT.C. İstanbul Yeni Yüzyıl Universitesi, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-7113-8504
Ordu University · TRBakırköy Psychiatric Hospital · TRIstanbul Yeni Yüzyıl University · TRYahoo (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn our study, the aim was to identify the serum uric acid levels, a marker of oxidative stress, according to migraine subtypes (aura/without aura and episodic/chronic migraine).

methodThe study included 300 migraine patients and 150 healthy controls for a total of 450 individuals. Migraine and subtypes were diagnosed according to International Classification of Headache Disorders-2013 criteria. Patients were evaluated during attendance at the neurology clinic.

resultsOur patient group was 77.0% female and disease duration was 9.2 ± 7.2 years. Our control group comprised 77.3% females. The age intervals in the patient and control groups were 36.4 ± 10.4 years and 36.0 ± 8.1 years. There was no statistically significant difference between our control and patient groups in terms of age and gender (p = .937 and p = .655). The serum UA, ferritin, and urea levels in our patient group were found to be significantly low compared to the healthy control group (p < .001). The serum UA levels in the migraine and control groups were 3.7 ± 0.7 and 4.6 ± 0.7 mg/dL, respectively (p < .001). There were no statistically significant differences observed between serum uric acid levels and other blood parameters between aura/without aura and episodic/chronic migraine subtypes (p > .05).

conclusionOur study supports the hypothesis that the oxidative stress marker of serum uric acid levels may be associated with migraine diagnosis, concluding that serum uric acid levels were not significant for migraine subtypes.

Indexed as

Headache DisordersMigraine DisordersMigraine with AuraAdultBiomarkersFemaleHeadacheHumansMaleMiddle AgedUric AcidBiomarkersUric AcidChronic migraineEpisodic migraineMigraineMigraine with auraMigraine without auraOxidative stressUric acid

Identifiers

PMID32691177
OpenAlexW3042664214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.